| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |